Nursing Perspectives on Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma

Guest Editor
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C

The supplement and associated publication costs were funded by Onyx Pharmaceuticals, Inc. Fishawack Communications, Inc., provided medical writing and editorial assistance, supported by Onyx Pharmaceuticals.


Review Article

Relapsed or Relapsed/Refractory Multiple Myeloma

Sandra E. Kurtin, RN, MS, AOCN®, ANP-C

Read More
Prescriber's Corner

Carfilzomib

J. Michael Vozniak, PharmD, BCOP

Read More
Review Article

The Side Effect Profile of Carfilzomib: From Clinical Trials to Clinical Practice

Laura McBride, RN, BSN, OCN®, CCRP, and Christine O. Samuel, RN, BSN, OCN®, CCRP

Read More
Grand Rounds

Treatment of Patients With Multiple Myeloma: A Relapsed and Refractory Case Study

Sandra E. Kurtin, RN, MS, AOCN®, ANP-C

Read More
Review Article

Treatment With Carfilzomib: A Promising Future for Multiple Myeloma

Donna Catamero, ANP-BC, OCN®, CCRC, and Charise Gleason, MSN, ANP, AOCNP®

Read More
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.